Collaboration reinforces regulatory diligence, nonclinical strategy and clinical trial integrity for novel intranasal concussion therapy Traumatic brain injuries affect more Americans each year than stroke, Alzheimer’s disease, Parkinson’s disease, …

Mark A. MahoneyFeb. 3, 2026, 5:01 a.m. ET Alzheimer’s disease is a growing public health crisis in Florida, and the impact of Alzheimer’s is projected to rise. A comprehensive public health approach is essential to improve community health, support the …

Newswise — Philadelphia—Researchers at the Alzheimer’s Center at Temple University (ACT) have published a comprehensive new review examining how two hallmark proteins of Alzheimer’s disease, amyloid-β and tau, interact and reinforce one another to drive …

- Company expects to receive a negative opinion following oral explanation feedback and intends to request re‑examination upon review of formal adoption. Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the Company was informed by the …

POTOMAC, MARYLAND / ACCESS Newswire / February 2, 2026 / IGC Pharma, Inc. (NYSE American:IGC) ("IGC" or the "Company"), today reported it has reached approximately 70% of planned patient enrollment in its Phase 2 CALMA …

Feb. 1, 2026, 5:04 a.m. ET Support Alzheimer’s Awareness bill Alzheimer’s is a public health crisis in Lakeland. More than 1 in 9 adults age 65-plus live with Alzheimer’s disease in Polk County, totaling nearly 18,000 residents. Florida has the second- …

Feb. 1, 2026, 5:04 a.m. ET In 2018, Massachusetts led the nation on Alzheimer's and dementia preparedness, passing the most comprehensive state legislative package in U.S. history. Today, though, the nation's bastion of science and medicine has …

There's still so much we don't know about Alzheimer's disease, but the link between poor sleep and worsening disease is one that researchers are exploring with gusto. A study published in 2023 found that using sleeping pills to get some shut- …

Without much fanfare, Health Canada announced in the Canada Gazette Part 1 on Dec. 22, 2025 that it was beginning a 70-day consultation period on using the decisions of foreign drug regulators such as the U.S. Food and Drug Administration (FDA) and the …

For some time, we've known that it's rare to see people with both cancer and Alzheimer's disease. Now, scientists believe they may have found why, discovering a molecule in cancer cells that clears problem proteins from the brain. Following 15 …